Aposense has received the 2008 European Technology Innovation of the Year Award in molecular/cellular imaging for its Aposense technology platform used in targeting and imaging of apoptosis, also known as programmed cell death, in medical imaging, personalized medicine and drug-development applications. The award is given to a company that has undertaken innovative research and whose work is expected to impact future adoption, change and competitive trends in the industry.

Related Summaries